The distributions of APOE genotypes and allele frequencies were significantly different between AD cases and controls in all ethnic groups (Tables S3 and S4) with increasing odds of AD among carriers of the ε4 allele in a dose-dependent manner and lower odds of AD among ε2 carriers (Table 1 and Tables S5). This evidence concerns the gene APOE and Alzheimer disease.